secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2026-05-21T10:02:22+00:00
Accession:  0001140361-26-022311
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharmaceuticals stockholders elect directors, ratify auditor, approve say-on-pay and stock option exchange
--------------------------------------------------------------------------------

- Seven director nominees elected; David P. Southwell received 43.2M for, 20.1M withheld (lowest support).
- Ratification of EisnerAmper as independent auditor: 79.2M for, 1.0M against, 0.6M abstain.
- Non-binding advisory vote on executive compensation approved: 61.4M for, 1.7M against, 0.2M abstain.
- Stock option exchange program approved with 45.6M for, 17.6M against (significant opposition).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036126022311/0001140361-26-022311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036126022311/ef20074449_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-022311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer